Showing results (281-290 of 439) with videos related to

Sort By:
Pageof 44
European Heart Journal|September 30, 2008
Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programmeStuart J Pocock, John J V McMurray, Joanna Dobson, et al.
European Heart Journal|August 23, 2021
Novel biomarker-driven prognostic models to predict morbidity and mortality in chronic heart failure: the EMPEROR-Reduced trialStuart J Pocock, João Pedro Ferreira, John Gregson, et al.
The American Journal of Cardiology|November 13, 2016
Gender Differences in Associations Between Intraprocedural Thrombotic Events During Percutaneous Coronary Intervention and Adverse OutcomesMikkel M Schoos, Roxana Mehran, George D Dangas, et al.
European Journal of Heart Failure|September 10, 2022
Heart failure outcomes according to heart rate and effects of empagliflozin in patients of the EMPEROR-Preserved trialMichael Böhm, Javed Butler, Felix Mahfoud, et al.
British Medical Journal|July 5, 1980
Maternal vitamin D intake and mineral metabolism in mothers and their newborn infantsF Cockburn, N R Belton, R J Purvis, et al.
Journal of the American College of Cardiology|September 24, 2021
Prognostic Importance of NT-proBNP and Effect of Empagliflozin in the EMPEROR-Reduced TrialJames L Januzzi, Faiez Zannad, Stefan D Anker, et al.
JACC. Heart Failure|October 25, 2024
Uric Acid and SGLT2 Inhibition With Empagliflozin in Heart Failure With Preserved Ejection Fraction: The EMPEROR-Preserved TrialWolfram Doehner, Stefan D Anker, Javed Butler, et al.
European Journal of Heart Failure|November 15, 2023
Growth differentiation factor-15 and the effect of empagliflozin in heart failure: Findings from the EMPEROR programJoão Pedro Ferreira, Milton Packer, Javed Butler, et al.
International Journal of Cardiology|March 8, 2017
Longer-term oral antiplatelet use in stable post-myocardial infarction patients: Insights from the long Term rIsk, clinical manaGement and healthcare Resource utilization of stable coronary artery dISease (TIGRIS) observational studyShaun G Goodman, Jose C Nicolau, Gema Requena, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 2, 2015
Prediction of 1-year mortality and impact of bivalirudin therapy according to level of baseline risk: A patient-level pooled analysis from three randomized trialsJennifer Yu, Roxana Mehran, Tim Clayton, et al.
Pageof 44